Navigation Links
30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho
Date:6/13/2008

Paris, France, Friday 13 June 2008: Tocilizumab plus methotrexate showed significant clinical improvements in efficacy and safety in patients with moderate to severe rheumatoid arthritis (RA), who had not adequately responded to anti-tumour necrosis factor (anti-TNF) therapy, according to a new study presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. Tocilizumab, an anti-interleukin (IL)-6 receptor monoclonal antibody, was demonstrated to be effective irrespective of the number of, or the most recently-failed anti-TNF treatments.

After 24 weeks of treatment, 30.1% (p<0.0001) of patients receiving 8mg/kg tocilizumab plus methotrexate, who had active RA despite prior anti-TNF therapy, achieved DAS28 (a measure of disease remission) compared with only 1.6% in the placebo arm. 50% (p<0.0001) of patients on the same regime achieved the study's primary endpoint of ACR20 (a 20% improvement in symptoms) compared to 10% of patients in the placebo arm. Patients receiving 4mg/kg tocilizumab plus methotrexate experienced similar, though slightly lower results with 7.6% (p=0.0533) achieving DAS28 and 30.4% (p<0.0001) achieving ACR20.

Professor Paul Emery of Leeds Teaching Hospital Trust / Leeds University, UK, lead investigator in the trial, said: "Although anti-TNF therapies for RA are well-established, a substantial number of patients are inadequately controlled by these treatments, or become refractory to them. The results of this trial suggest that tocilizumab offers a much needed and effective option for such patients."

The RADIATE study was a randomised, double-blind study of 499 patients with moderate to severe RA. 12-18% of patients had 3 or more prior anti-TNF failures. A low proportion of the patients in the 8mg/kg tocilizumab group experienced serious adverse effects (6%) or serious infections (5%) during the trial. There was no difference in safety or tolerability based on pr
'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
2. 13 percent of women stop taking breast cancer drug because of side effects, U-M study finds
3. Ninety Percent of Polled Pain Care Professionals Express Fear of Regulation
4. Health Insurance Premiums Rise 6.1 Percent in 2007, Less Rapidly Than in Recent Years But Still Faster Than Wages and Inflation
5. Less than 3 percent of UK 11-year-olds take enough exercise
6. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
7. Hospitals See Infection Rates More Than Halved, Patient Stays Shortened by 27 Percent in New Study Announced by I-Flow
8. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
9. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
10. New research shows ACTOS is associated with a 38 percent lower risk of heart attack
11. Sixty Percent of Americans Cannot Name Top Killers of Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... A common inflammatory muscle disorder that causes pain ... risk for heart attack and stroke, new ... patients with polymyalgia rheumatica are more likely to ... blood vessels. Doctors should carefully manage the vascular ... reduce their risk for complications, the study authors ...
(Date:7/28/2014)... A new study, published in the July, 2014, ... Cancer Institute by Northwestern Medicine researchers, sheds ... growing popularity of endoscopic resection in the treatment ... the more traditional surgical resection, while more invasive, ... five-year survival rate for patients than endoscopic resection, ...
(Date:7/28/2014)... Jose, CA (PRWEB) July 28, 2014 ... family life Americans face today, BlogHer, The Center for ... to launch “Make Life Work,” a campaign to raise ... by families across the U.S. The joint initiative was ... Stacy Morrison, Editor-in-Chief, BlogHer; Judith Warner, Senior Fellow, The ...
(Date:7/28/2014)... 2014 The website, which is hosted ... industry, went live in January 2014. The honor recognizes ... of excellence that comprise the web’s most professional work. ... , “What pleases me the most is that we ... categories,” said Joshua Snow, web manager, Abington Health. “We ...
(Date:7/28/2014)... Synergy Business Solutions announced today it was chosen ... list of top 100 value added resellers (VAR) of ... is the eighth year since 2006 that Synergy has ... success in terms of revenue, growth, and accounting software ... to be counted among such a reputable list of ...
Breaking Medicine News(10 mins):Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5Health News:Abington Health Website Named Best in Class 2Health News:Synergy Business Solutions Selected to Top 100 VAR List for Eighth Year by Accounting Today 2Health News:Synergy Business Solutions Selected to Top 100 VAR List for Eighth Year by Accounting Today 3
... Breast Cancer Test MammaPrint(R), AMSTERDAM, the Netherlands, ... Dutch breast cancer test as one of the ... Ball" (MammaPrint(R)) invented and,developed by the International company ... to support the choice of treatment,for that specific ...
... SYNAPT High ... Definition MS System, MILFORD, Mass. ... announced today that the University of,Leeds, Astbury Centre for Structural Molecular ... Waters(R),SYNAPT High Definition MS(TM) (HDMS) System in the Journal of the ...
... WASHINGTON, Dec. 4 In conjunction with,National Handwashing ... Control and Epidemiology presents information on,Methicillin-resistant Staphylococcus aureus ... So what,s the story with MRSA?, MRSA ... and many other,antibiotics. MRSA infections often start as ...
... finds breast cancer patients who lack insurance, who come from ... who are older are less likely to get a key ... those groups are ten percent to three times more likely ... has spread to axillary (underarm) lymph nodes. An abstract of ...
... may not be a more feared dental procedure than a ... is choosing the right professional to perform the procedure. Painful ... to advances pioneered by endodontists, the root canal specialists. In ... of individuals who previously underwent a root canal by an ...
... , TUESDAY, Dec. 4 (HealthDay News) -- Disorganized, meandering tracts ... of dyslexia marked by slow and choppy reading fluency, U.S. ... affects 5 percent to 15 percent of children. , In ... Deaconess Medical Center used a special form of MRI called ...
Cached Medicine News:Health News:Time Magazine Names Agendia Test a Best Invention of 2007 2Health News:In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 2Health News:In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 3Health News:In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 4Health News:In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 5Health News:In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 6Health News:MRSA Facts for Handwashing Week 2Health News:Uninsured, others less likely to receive breast cancer test 2Health News:Survey confirms Americans prefer root canal treatment by endodontists 2Health News:Nerve Disorganization May Spur Form of Dyslexia 2
(Date:7/28/2014)... July 28, 2014  VigeneTech, Inc, in collaboration ... LEGENDplex™ Data Analysis Software, an OEM software solution ...  BioLegend develops and offers varieties of bead-based multi-analyte ... the support of VigeneTech,s data analysis software, FCS ... and easily reported LEGENDplex™ software ...
(Date:7/28/2014)... Ala. , July 28, 2014 ... J. Tipton , Ph.D., President and CEO of ... the Controlled Release Society (CRS) for the 2014-2015 ... annual meeting on July 12 in ... 40 countries.  The Controlled Release ...
(Date:7/28/2014)... , July 28, 2014 Research and ... Arthritis Drugs Market 2014-2018" report to their offering. ... a chronic disease that leads to inflammation and pain in ... and ankles. In addition, it causes inflammation of the tissues ... The symptoms of RA begin slowly, usually just ...
Breaking Medicine Technology:VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3Global Rheumatoid Arthritis Drugs Market 2014-2018 2
... PITTSBURGH, Sept. 1 invivodata inc., the ... for global clinical research, today announced that the company has been ... privately-held companies in Western Pennsylvania by the Pittsburgh Business Times. ... as one of the most important lists we publish," said Alan ...
... , NATICK, Mass., and BARCELONA, Spain, ... today announced final results from the landmark MADIT-CRT trial, which were ... presented during a Hot Line session at the annual European Society ... To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/bostonscientific/36500/ ...
Cached Medicine Technology:invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies 2invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies 3Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression 2Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression 3Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression 4Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression 5
... Well Plate Capability The Equalizer 384 ... Equalizerexpandable and equal tip spacing, choice of two ... In addition, this model allows you to evenly ... and accessing many gels and for use with ...
... A lower cost alternative to Equalizers, the patented ... between two different vessel configurations. With the push ... be quickly and easily adjusted for test tubes ... Ergonomic Design for Unparalleled Comfort Pick one ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: